Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,275 | -13,727 | -60,478 | 4,408 | -29 |
| Depreciation Amortization | 509 | 404 | 378 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,964 | 1,686 | 1,114 | N/A | N/A |
| Other Working Capital | -2,725 | -6 | 293 | 738 | -532 |
| Other Operating Activity | 18,126 | -355 | 50,521 | -5,362 | -153 |
| Operating Cash Flow | $-12,329 | $-11,999 | $-8,171 | $-215 | $-714 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | N/A | -133 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -351,900 |
| Investing Cash Flow | $-64 | $N/A | $-133 | $N/A | $-351,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,400 | 1,000 | 4,000 | N/A | N/A |
| Common Stock Issued | 4,862 | N/A | N/A | N/A | 353,525 |
| Other Financing Activity | 3,400 | 11,229 | -128 | 0 | -567 |
| Financing Cash Flow | $11,662 | $12,229 | $3,872 | $N/A | $352,958 |
| Beginning Cash Position | 1,283 | 1,052 | 5,484 | 345 | N/A |
| End Cash Position | 552 | 1,283 | 1,052 | 129 | 345 |
| Net Cash Flow | $-731 | $231 | $-4,432 | $-215 | $345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,329 | -11,999 | -8,171 | -215 | -714 |
| Capital Expenditure | -64 | N/A | -133 | N/A | N/A |
| Free Cash Flow | -12,393 | -11,999 | -8,304 | -215 | -714 |